Gilmer Daniel B. 4

What Happened

• Daniel B. Gilmer, a director of Armata Pharmaceuticals, was granted a derivative award on 2026-04-24 covering 51,280 shares (reported as $0.00 per share). This was a grant/award of options (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-04-24; Form 4 filed: 2026-04-28 (timely filing).
• Transaction type: Award/Grant of a derivative security (stock option) covering 51,280 underlying shares; reported price: $0.00.
• Shares owned after transaction: Not specified in the filing.
• Footnote: The option vests one-third of the underlying shares on each of the first, second and third anniversaries of the grant date, subject to continued service.
• Transaction codes: A = Award/Grant; This is not an exercise (no immediate acquisition of shares) and not a sale.

Context

• This filing reports a typical equity compensation grant to a director. The award gives the right to acquire shares subject to vesting; it does not represent an immediate cash purchase or sale. Such grants are common as compensation and do not by themselves indicate insider buying or selling activity.